Peptide and treatment for HIV-1 infection

Details for Australian Patent Application No. 2007328228 (hide)

Owner Thomas Jefferson University Oyagen Inc.

Inventors Zhang, Hui; Smith, Harold C.

Agent King & Wood Mallesons

Pub. Number AU-B-2007328228

PCT Pub. Number WO2008/070049

Priority 60/873,186 06.12.06 US

Filing date 4 December 2007

Wipo publication date 12 June 2008

Acceptance publication date 20 September 2012

International Classifications

C07K 5/00 Peptides having up to four amino acids in a fully defined sequence

A61K 38/00 Medicinal preparations containing peptides

A61K 38/10 Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

C07K 7/00 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 9/00 Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/070049 Priority application(s): WO2008/070049

20 September 2012 Application Accepted

  Published as AU-B-2007328228

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007328233-Medical device including a slider assembly

2007328222-Trityl chloride recovery